Loading...
NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis
Peri, Suraj ; Izumchenko, Evgeny ; Schubert, Adrian D. ; Slifker, Michael J. ; Ruth, Karen ; Serebriiskii, Ilya G. ; Guo, Theresa ; Burtness, Barbara A. ; Mehra, Ranee ; Ross, Eric A. ... show 2 more
Peri, Suraj
Izumchenko, Evgeny
Schubert, Adrian D.
Slifker, Michael J.
Ruth, Karen
Serebriiskii, Ilya G.
Guo, Theresa
Burtness, Barbara A.
Mehra, Ranee
Ross, Eric A.
Citations
Altmetric:
Genre
Journal article
Date
2017-11-24
Advisor
Committee member
Department
Cancer and Cellular Biology
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
http://dx.doi.org/10.1038/s41467-017-01877-7
Abstract
Squamous cell carcinomas of the head and neck (SCCHN) affect anatomical sites including the oral cavity, nasal cavity, pharynx, and larynx. Laryngeal cancers are characterized by high recurrence and poor overall survival, and currently lack robust molecular prognostic biomarkers for treatment stratification. Using an algorithm for integrative clustering that simultaneously assesses gene expression, somatic mutation, copy number variation, and methylation, we for the first time identify laryngeal cancer subtypes with distinct prognostic outcomes, and differing from the non-prognostic laryngeal subclasses reported by The Cancer Genome Atlas (TCGA). Although most common laryngeal gene mutations are found in both subclasses, better prognosis is strongly associated with damaging mutations of the methyltransferases NSD1 and NSD2, with findings confirmed in an independent validation cohort consisting of 63 laryngeal cancer patients. Intriguingly, NSD1/2 mutations are not prognostic for nonlaryngeal SCCHN. These results provide an immediately useful clinical metric for patient stratification and prognostication.
Description
Citation
Peri S, Izumchenko E, Schubert AD, Slifker MJ, Ruth K, Serebriiskii IG, et al. NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis. Nat Commun. 2017 Nov 24;8. doi:10.1038/s41467-017-01877-7.
Citation to related work
Nature Research
Has part
Nature Communications, Vol. 8
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu